E2 ModerateModerate confidencePEM ?Cross-SectionalPeer-reviewedMachine draft
Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.
Nacul, Luis C, Lacerda, Eliana M, Pheby, Derek et al. · BMC medicine · 2011 · DOI
Quick Summary
This study looked at how many people in three regions of England have ME/CFS by checking medical records and asking doctors directly about their patients. Depending on which diagnostic criteria they used, between 0.03% and 0.2% of adults had ME/CFS—meaning roughly 1 in 500 to 1 in 3,300 people. The study shows ME/CFS is a real and significant health problem affecting many people who need better support and care.
Why It Matters
This study provides epidemiological evidence for healthcare planning and resource allocation by establishing ME/CFS prevalence in England. It demonstrates that ME/CFS affects a significant proportion of the population with high unmet healthcare and social care needs, supporting the case for improved clinical recognition, service provision, and research funding. The comparison of case definitions has implications for standardizing diagnosis internationally and identifying distinct patient subgroups for targeted research.
Observed Findings
- Minimum prevalence of ME/CFS meeting any case definition was 0.2% (approximately 1 in 500 people), with CDC-1994 at 0.19%, Canadian definition at 0.11%, and ECD at 0.03%.
- Minimal yearly incidence was estimated at 0.015%.
- London had the highest prevalence rates while East Yorkshire had the lowest, indicating significant regional variation.
- Nearly all cases meeting Canadian criteria also met CDC-1994 criteria, but Canadian cases showed higher symptom prevalence and severity.
- A substantial proportion of people with chronic fatigue did not meet specific ME/CFS diagnostic criteria but still required healthcare and social services.
Inferred Conclusions
- ME/CFS is not uncommon in England and represents a significant disease burden requiring health and social care provision.
- The choice of case definition substantially affects prevalence estimates, supporting the need for standardized combined criteria (CDC-1994 + Canadian) for international comparisons.
- Systematic use of combined case definitions with careful clinical phenotyping will enable identification of distinct patient subgroups that may have different etiologies and pathophysiologies, potentially leading to targeted treatments.
- Both diagnosed ME/CFS cases and chronic fatigue cases not meeting specific criteria have significant service needs that current healthcare systems may not adequately address.
What This Study Does Not Prove
This study does not establish the causes of ME/CFS or explain why prevalence varies geographically. It does not prove that all chronic fatigue cases are ME/CFS, nor does it identify biological mechanisms or biomarkers. The prevalence estimates represent minimums, so actual prevalence may be higher; the study's cross-sectional design cannot establish causation or long-term disease outcomes.
Tags
Symptom:Fatigue
Method Flag:No ControlsStrong Phenotyping
Metadata
- DOI
- 10.1186/1741-7015-9-91
- PMID
- 21794183
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026